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Abstract
Histopathology tissue analysis is considered the gold standard in cancer di-
agnosis and prognosis. Whole slide imaging, i.e., the scanning and digitization
of entire histology slides, are now being adopted across the world in pathol-
ogy labs. Trained histopathologists can provide an accurate diagnosis of biopsy
specimens based on whole slide images (WSI). However, given the large size
of these images and the increase in the number of potential cancer cases, an
automated solution as an aid to histopathologists is highly desirable. In the re-
cent past, deep learning-based techniques, namely, CNNs, have provided state
of the art results in a wide variety of image analysis tasks, including analysis of
digitized slides. However, the size of images and variability in histopathology
tasks makes it a challenge to develop an integrated framework for histopathology
image analysis. We propose a deep learning-based framework for histopathol-
ogy tissue analysis. We demonstrate the generalizability of our framework,
including training and inference, on several open-source datasets, which include
CAMELYON (breast cancer metastases), DigestPath (colon cancer), and PAIP
(liver cancer) datasets. Our segmentation pipeline is an ensemble of DenseNet,
InceptionResnet-V2, and DeeplabV3Plus, where all the networks for each task
were trained end to end. We experimentally demonstrate the efficacy of trans-
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ferring model learning from one cancer site to another. We discuss multiple
types of uncertainties pertaining to data and model, namely aleatoric and epis-
temic, respectively. Simultaneously, we demonstrate our model generalization
across different data distribution by evaluating some samples on TCGA data.
Our framework provides segmentation maps along with uncertainty maps for a
given WSI. On CAMELYON16 test data (n=139) for the task of lesion detec-
tion, the FROC score achieved was 0.86 and in the CAMELYON17 test-data
(n=500) for the task of pN-staging the Cohen’s kappa score achieved was 0.9090
(third in the open leaderboard). On DigestPath test data (n=212) for the task
of tumor segmentation, a Dice score of 0.782 was achieved (fourth in the chal-
lenge). On PAIP test data (n=40) for the task of viable tumor segmentation,
a Jaccard Index of 0.75 (third in the challenge) was achieved, and for viable
tumor burden, a score of 0.633 was achieved (second in the challenge). Our
entire framework and related documentation are freely available at GitHub and
PyPi.
Keywords: Whole slide image, Deep learning, Segmentation, Biomedical
imaging, Tumor burden, Convex hull, Fully convolutional neural networks,
Breast cancer, Lymph node metastases, Liver cancer, Colon cancer,
pN-Staging
1. Introduction
Histopathology is still the only definitive method to diagnose cancer (Sala-
mat, 2010). Early diagnosis of cancer significantly increases the probability
of survival (Hawkes, 2019). Unfortunately, pathological analysis is an ardu-
ous process that is difficult, time-consuming, and requires in-depth knowledge.
A study conducted by (Elmore et al., 2015) investigated the concordance of
pathologists investigating biopsies of the breast. This study comprised of 115
pathologists across the United States and 240 biopsy specimens. It was found
that pathologists disagreed with each other on a diagnosis 24.7% of the time on
average. This high rate of misdiagnosis stresses the need to develop computer-
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aided methods for histopathology analysis to aid the pathologists. With the
increasing prevalence of whole-slide imaging(WSI) scanners that can scan the
entire tissue sample, in-silico methods of conducting pathology analysis can now
be explored (Madabhushi and Lee, 2016).
Broadly, histopathology analysis includes two types, namely (1) Classifica-
tion analysis and (2) Segmentation analysis. Classification analysis helps in
classifying WSI into benign or malignant (Nanthagopal and Rajamony, 2013),
(Guray and Sahin, 2006). Classification can also be used to study cancer sub-
types directly (Malhotra et al., 2010). Segmentation analysis helps in detecting
and separating tumor cells from the normal cells (Wa¨hlby et al., 2004), (Xu
et al., 2016). This analysis can also be used for the aforementioned classifica-
tion task and other analyses like pN-staging and tumor burden estimation.
Automatic histopatholgy analysis is plagued by a myriad of challenges (Tizhoosh
and Pantanowitz, 2018);
1. Insufficient training samples: As the data extraction process for medical
images is expensive and less frequent, this results in class imbalance issues,
adding an inherent skewness to the dataset. This makes it hard to adapt
algorithms which are developed for natural images to medical data.
2. Large dimensionality of WSI: A WSI is generated by digitizing a glass
slide at a very high resolution of order 0.25 micrometers/pixel (which
corresponds to 40X magnification on a microscope). A typical glass-slide
of size 20mm x 15mm results in gigapixel image of size 80,000 x 60,000
pixels.
3. Stain variability across laboratories: As the data is acquired from multiple
sources, there exists a lack of uniformity in staining protocol. Building
a generalized framework that is invariant to stain pattern variability is
challenging.
4. Extraction of clinically relevant features and information. Another major
challenge is trying to extract features that are meaningful from a clini-
cal point of view. Deep learning does an excellent task of automatic fea-
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ture extraction, but understanding these extracted features and extracting
meaningful information from them is challenging.
The organization of the paper is as follows. Prior work on histopathology
tissues using deep learning methods are discussed in the section 1.1, Followed by
our contributions in section 1.2. In section 2.2 we introduce the datasets used
in this work, all the preprocessing techniques are discussed in section 2.3. In
section 2.4, we discuss multiple deep convolutional networks used, followed by
training and inference pipelines in section 2.7 and 2.8 respectively. In section 2.9,
2.10, and 2.6 we describe various other concepts like pN-staging, tumor burden,
and uncertainty analysis. Experimental analysis and comprehensive results are
presented in section 3 and 4. In section 5 we describe our open-source project
(DigiPath AI) and in section 6 we discuss our results and conclude with future
direction of work.
1.1. Related work
1.1.1. Deep learning methods for histopathology image analysis
Deep learning methods have shown great success in various tasks involving
image, graph, and text data. In the field of medical imaging and diagnosis,
deep learning models have achieved human-like results on many specific prob-
lems (Kermany et al., 2018), (Bakas et al., 2018), (Weng et al., 2017), (Ra-
jpurkar et al., 2017). One possible medical application where deep learning
could have a very high impact if leveraged accurately would be the automation
of histopathology analysis. In recent years, grand challenges (Li et al., 2019;
CAM, 2017a,b; PAIP, 2019; ICAIR, 2019) are encouraging all the researchers
to collectively work on histopathological data using deep learning based solu-
tions, by providing labeled data.
Histopathology slides provide a more comprehensive view of diseases on the
tissue and is still considered as a gold standard for cancer diagnosis (Gurcan
et al., 2009). In recent past many deep learning-based methods have approached
problems of nuclei segmentation (Sirinukunwattana et al., 2016), liver tumor seg-
mentation (Kaluva et al., 2018), epithelial tumor tissue segmentation (Shapcott
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et al., 2019), Gleason grading (Arvaniti et al., 2018), signet ringcell detection (Li
et al., 2019) and many more. Deep learning-based methods are increasingly used
in the context of histopathology analysis because of their ability to automati-
cally discover the representations needed for feature detection from raw data.
Deep learning has also helped in merging multi-domain information (Bagari
et al., 2018) in diagnosis, since they learn to associate important features from
each domain, and has been proven to provide better results.
1.1.2. Lymph node metastases of breast cancer
Breast cancer is one of the most common cancer among women in the world.
The prognosis of breast cancer patients is mainly based on the extent of metas-
tases (Sites, 2014). Metastases refers to the spreading of cancer to different
parts of the body from where it originally started. This usually occurs when
cancer cells break away from the main tumor and enter the bloodstream or
lymphatic system. A formally accepted way to classify the extent of cancer is
based on TNM staging criteria (Amin and Edge, 2017; Sobin et al., 2011). The
TNM staging system takes into account the size of the tumor (T-stage), cancer
spreading to regional lymph nodes (N-stage) and metastasization of tumor to
other parts of the body (M-stage). In case of breast cancer, the lymph nodes are
usually the first location to get metastasized. With the help of sentinel lymph
node procedure (Giuliano et al., 2011, 2017), the most likely metastasized lymph
nodes are excised and taken for further histopathological processing and exam-
ination by a pathologist. The excised node is preserved by fixing in formalin
and embedded in paraffin wax block to enable cutting micrometers thin slices
of the tissue. These tissue slices are placed on glass slides and are stained with
hematoxylin and eosin (H&E). This staining enables the pathologist to differ-
entiate between nuclear (blue) and cytoplasmic parts (pink) of the cell, thereby
providing a general overview of the tissue’s structure.
Clinically, metastases is divided into one of the three categories namely:-
isolated tumor cells (ITC), micro-metastases and macro-metastases. The cat-
egorization is based on the diameter of the largest tumor cells cluster. The
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Table 1: Size criteria for assigning metastasis type
Category Size
Isolated tumor cells
Single tumor cells or a cluster of
tumor cells not larger than 0.2
mm or less than 200 cells
Micro-metastasis
Larger than 0.2 mm and/or con-
taining more than 200 cells, but
not larger than 2 mm
Macro-metastasis Larger than 2 mm
Table 1 provides the size criteria for metastases type. The assigning of patho-
logic N-stages (pN-stages) is based on metastases size and number of lymph
nodes per patient (Sobin et al., 2011). A simplified version of the pN-staging
scheme used in CAMELYON17 Challenge (Bejnordi et al., 2017) is provided in
Table 2. However, this diagnostic procedure in assessing lymph nodes status is
challenging for pathologists as large tissue area has to be examined in detail un-
der microscope at several magnification levels for identifying metastases. Also,
this process is tedious, prone to missing small metastases and would require
extensive time by pathologist for a thorough examination.
The advent of whole-slide imaging scanners has enabled digitization of glass-
slides at very high resolution. Typical whole-slide images (WSI) are in order of
gigapixels and usually stored in multi-resolution pyramidal format. These WSIs
are suitable for developing computer aided diagnosis systems for automating
the pathologist workflow and also with the availability of large amount of data
makes WSIs amenable for analysis with machine learning algorithms. Some of
the earliest works (Wolberg et al., 1994; Diamond et al., 2004; Petushi et al.,
2006) based on machine learning algorithms for digital pathology and WSIs were
cancer classification.
Recently, with advent of convolutional neural networks (CNNs) considerable
6
Table 2: Pathologic lymph node classification (pN-stage) in CAMELYON17 Challenge
pN-Stage Slide Labels
pN0 No micro-metastases or macro-metastases or ITCs found.
pN0(i+) Only ITCs found.
pN1mi Micro-metastases found, but no macro-metastases found.
pN1 Metastases found in 1-3 lymph nodes, of which at least
one is a macro-metastasis.
pN2 Metastases found in 4-9 lymph nodes, of which at least
one is a macro-metastasis.
improvements have been shown in various computer vision tasks like detection,
segmentation and classification. CNNs have also been proposed in lymph node
metastasis detection in the recent years (Litjens et al., 2016; Paeng et al., 2017;
Liu et al., 2017; Lee and Paeng, 2018; Li and Ping, 2018; Wang et al., 2018).
1.1.3. Colorectal carcinoma
Colorectal carcinoma is third most common cancer in the United States
(Fleming et al., 2012). Majority of colorectal carcinoma are adenocarcinomas
originating from epithelial cells (Hamilton, 2000). Shapcott et al. (2019) discuss
the application of deep learning methods for cell identification on TCGA data.
Kather et al. (2019) discuss the deep learning methods to predict the clinical
course of colorectal cancer patients based on histopathological images and By-
chkov et al. (2018) discuss the use of LSTM (Greff et al., 2016) for estimating
the patient risk score using spatial sequential memory.
1.1.4. Liver cancer
Three out of every four cases of liver cancer results in death, making it one of
the deadliest forms of cancer (Stewart et al., 2019). Amongst the different forms
of liver cancer, hepatocellular carcinoma is the most common form(Chuang
et al., 2009). Computer-aided methods for detecting liver cancer from vari-
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ous modalities such as CT (Li et al. (2015), Yasaka et al. (2017)), ultrasound
(Wu et al., 2014) and laparoscopy (Gibson et al., 2017) have been explored.
Methods utilizing multi-omics data such as RNA sequencing have also been
successful (Chaudhary et al., 2018). However, for histopathology, lack of anno-
tated datasets comprising of liver tissue images in this modality has rendered
this area unexplored. The new grand challenge PAIP (2019) on liver cancer
segmentation motivates research in this area.
1.2. Contributions
In this paper, we developed an end-to-end framework for histopathology
analysis from WSI images that generalizes well with various cancer sites. The
framework comprises of segmentation at its core along with novel algorithms
that utilize the segmentation to do pathological analyses such as metastasis
classification, viable tumor burden estimation, and pN-staging. As discussed in
section 1, challenges in WSI analysis are mainly due to their extremely large size,
variability in staining, and the limited amount of data. In this work, we propose
a few key contributions which helped in addressing a few of the aforementioned
problems.
• Extremely large size of WSI: we propose an efficient patch-based approach
for training and inference, where sampling is done on a generated tissue
mask, thereby reducing computations on unnecessary patches.
• Insufficient data: To address the problems of limited data and class im-
balance, we made use of overlapping and oversampling based strategies in
patch extraction along with multiple data augmentations.
• Inference Pipeline: To remove the edge artifacts characteristic of patch-
based segmentation, we have proposed an overlapping strategy, which
proved to reduce them significantly.
• pN Staging: We combined and experimented on various strategies of over-
sampling and under-sampling techniques to address class imbalance prob-
lem in the dataset for metastases classification.
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• Whole tumor segmentation: We propose an empirical non-deep learning
based approach for estimating the whole tumor region from the viable
tumor region that is computationally efficient yet performs on par with
the deep learning based methods.
• Uncertainty Estimation: We have proposed an efficient patch-based un-
certainty estimation framework, to estimate both data specific and model
(parameter) specific uncertainties.
• Transfer Learning: Based on our study, we show that transfer learning us-
ing CAMELYON dataset helps in faster convergence for other histopathol-
ogy datasets.
• Generalizability: We bench-marked the performance of our methods by
validating it on multiple open-source datasets including CAMELYON
(Litjens et al., 2018), (Bejnordi et al., 2017), (Bandi et al., 2018) Di-
gestPath(Li et al., 2019), and PAIP(PAIP, 2019).
• Open-source Packaging: Finally, we packaged the framework into an open-
source GUI application for the benefit of researchers.
2. Materials and methods
2.1. Overview
The Figure 1, illustrates the proposed overall framework. The proposed
framework predicts segmentation mask along with uncertainty maps for a given
input image (liver or breast or colon tissue). In this framework we also define a
pipeline for pN staging, metastases classification, and tumor burden estimation.
2.2. Data
We made use of multiple open-source datasets including DigestPath19(Li
et al., 2019), PAIP19 (PAIP, 2019), CAMELYON(Bejnordi et al., 2017; Bandi
et al., 2018; Litjens et al., 2018) datasets to validate our framework.
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Figure 1: Entire framework pipeline
2.2.1. CAMELYON (CAncer MEtastases in LYmph nOdes challeNge)
The CAMELYON dataset comprises of sentinel lymph node tissue sections
collected from the CAMELYON16 (CM16) and CAMELYON17 (CM17) chal-
lenges. The CM16 dataset comprised of 399 WSIs taken from two medical
centers in the Netherlands, out of which 159 WSIs were metastases, and the
remaining 240 were negative. Pathologists exhaustively annotated all the WSIs
with metastases at the pixel level. In the CM16 challenge the 399 WSIs were
split into training and testing sets, comprising of 160 negative and 110 metas-
tases WSIs for training, 80 negative and 49 metastases WSIs for testing.
The CM17 dataset comprised of 1000 WSIs taken from five medical centers
in the Netherlands. In CM17 challenge, 500 WSIs were allocated for training,
and the remaining 500 WSIs were allocated for testing. The training dataset
of CM17 included 318 negative WSIs and 182 WSIs with metastases. In CM17
dataset, slide-level labels were provided for all the WSIs and exhaustive pixel
level annotations were provided for 50 WSIs. The slide-level labels were nega-
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Table 3: Metastases type distribution in CAMELYON17 training set
Metastases (Training Set)
Negative ITC Micro Macro
318 35 64 88
tive, Isolated Tumor cells (ITC), micro-metastases and macro-metastases (Table
1). In CM17 challenge, the 1000 WSIs were divided into 200 artificial patients,
and each artificial patient was constructed by grouping 5 WSIs from the same
medical center. The pN-stage labels were provided for 100 patients from the
training set based on the rules provided in Table 2. The Table 3 provides the
metastases type distribution in CM17 training dataset.
2.2.2. DigestPath
DigestPath dataset consists of a total of 750 tissue slices taken from 450
different patients. On average, each tissue image was of size 5000x5000. The
dataset also included fine pixel-level annotations of lesion done by experienced
pathologists. Additionally, 250 tissue slices taken from 150 patients were pro-
vided as a test set. The data was collected from multiple medical centers,
especially from several small centers in developing countries. All the tissues
were stained by hematoxylin and eosin (H&E) and scanned at 20x resolution.
Out of 750 tissue slices, 725 slices were used in training, and the rest 25 slices
we considered as a held-out test set.
2.2.3. PAIP
The PAIP dataset contains a total of 100 whole slide images scanned from
liver tissue samples. Each image had an average dimension of 50,000x50,000
pixels. All the images were stained by hematoxylin and eosin, scanned at 20x
magnification, and prepared from a single center, Seoul National University
Hospital. The dataset included pixel-level annotation of the viable tumor and
whole tumor regions. It also provided the viable tumor burden metric for each
image.
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Figure 2: In the above figure green contour represents viable tumor and the blue contour
represents whole tumor
Tumor burden is defined as the ratio of the viable tumor region to the
whole tumor region. The viable tumor region is defined as the cancerous region.
The whole tumor area is defined as the outermost boundary enclosing all the
dispersed viable tumor cell nests, tumor necrosis, and tumor capsule (Fig 2).
Each tissue sample contains only one whole tumor region. This metric has
applications in assessing the response rates of patients to cancer treatment.
Out of the 100 images, 50 images were the publicly available training set, 10
images were reserved for validation set that was made publicly available after
the challenge was completed, and the rest 40 images were the test set whose
ground truth were not publicly available.
2.3. Data pre-processing
2.3.1. Tissue mask generation
Tissue mask generation was done to prevent unnecessary computations on
blank spaces in tissue slice. In this step, the entire tissue region was separated
from the background glass region of the slide. Here we make use of Otsu’s
adaptive thresholding (Otsu, 1979) technique on the low-resolution version of
the WSI. The RGB color space of the low-resolution WSI was transformed to
HSV (Hue-Saturation-Value) color space, and thresholding was applied to the
saturation component. Post thresholding, morphological operations were done
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Dataset #WSIs Average image size #Number of patches extracted
CAMELYON 628 100,000x100,000 571,029
DigestPath 725 5,000x5,000 80,000
PAIP 50 50,000x50,000 200,000
to ensure that during patch-based inference of the WSI, the neighboring contexts
were appropriately provided in the extracted patches at small tissue regions and
tissue borders.
2.3.2. Patch coordinate extraction
The WSIs are gigapixel images, and the typical image sizes are of order
100k × 100k. We proposed to train our neural networks with small patches
of fixed size extracted from the WSI. We extracted coordinates as the center
of the patches from the low-resolution WSI’s tissue mask. We rescaled the
extracted coordinates to correspond to level-0 WSI. The randomly sampled
coordinates from the WSIs corresponded to regions from the tumor, tumor
boundary regions, and non-tumor tissue. From each WSI, a fixed number of
patch coordinates corresponding to various regions of WSIs were extracted.
Further, these extracted patch coordinates were split into three cross-validation
folds.
2.3.3. Data augmentation, normalization and data loading
To increase the number of data points and generalization of models to var-
ious staining and acquisition conditions, we made use of data augmentations.
Augmentations like flipping left, and right, 90-degree rotations, and Gaussian
blurring along with color augmentation were performed. Color augmentation in-
cluded random changes to brightness, contrast, hue, and saturation, the ranges
for which were 64.0/255, 0.75, 0.25, 0.04, respectively. Additionally, in order to
introduce a diversity of patches extracted from the WSI during every training
cycle, we incorporated random coordinate perturbation. The random coordi-
nate perturbation involved offsetting the center of the patch coordinates within
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a specified radius prior to the extraction from WSI. We fixed our radius to be
128 pixels and extracted patches of size 256x256 from the level-0 image.
Post augmentation, the images were normalized using equation 1 to scale
the range of data statistics, basically transforming the data to have zero mean
and unit standard deviation. Since the image dimensions were huge, computing
the image statistics during training was expensive. This was circumvented by
assuming the mean and standard deviation of the image to be 128, which spreads
the entire region.
Xnorm =
X − 128
128
(1)
The data-loader prepared batches of data comprising an equal number of
tumorous and non-tumorous patches, thereby facilitating a balanced dataset
for training the neural network.
2.4. Network architecture
For the task of segmentation of tumor regions from patches of WSIs, we pro-
pose to utilize encoder-decoder based fully convolutional neural (FCN) network-
based architectures (Long et al., 2015). An encoder comprises of a series of
operations (like convolution and pooling) that reduces the input size to a low
dimension feature vector. The decoder upsamples the feature vectors to a larger
dimension. The entire encoder-decoder is then trained end-to-end. Fully convo-
lutional architecture substitutes fully connected layers with convolutional layers,
thereby allowing input of arbitrary size. We propose an ensemble approach com-
prising of some of the FCN architectures that show the state of the art results
on natural images, namely Densenet, InceptionResNetV2, and DeepLabV3Plus.
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2.4.1. DenseNet
Figure 3: Densenet Architecture
We used a U-Net (Ronneberger et al., 2015) based encoder-decoder archi-
tecture. The main feature of U-Net is the presence of skip connections between
layers of the encoder and decoder. These connections allow for the free flow of
low-level information directly from the encoder to the decoder, bypassing the
bottleneck. The skip-connection was made by concatenating the lth layer with
the (n− l)th layer.
For the encoder, we use the DenseNet (Iandola et al., 2014) architecture.
The input for a particular layer in the DenseNet network was concatenated to
inputs of all the previous layers. This was done to prevent the loss of information
through forward pass in deep networks. The decoder was composed of the bi-
linear up-sampling module and convolutional layers.
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2.4.2. Inception-ResNetV2
Figure 4: Inception-ResNetV2 architecture
The Inception-v4 (Szegedy et al., 2017) (also known as Inception-ResNetV2)
integrates the features of the Inception (Szegedy et al., 2015) architecture and
the ResNet (He et al., 2016) architecture. The ResNet architecture introduced
skip-connections between layers by summing the input and output of the (l−1)th
layer and feeding that as the input for the lth layer. The Inception architecture
contains inception blocks that have convolutions of various sizes. This waives
the need to deliberate on the filter sizes for each layer.
In the Inception-ResNet’s architecture, the inception blocks have skip con-
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nections that sum the input of the block to the output.
2.4.3. DeepLabV3Plus
Figure 5: DeepLabV3Plus architecture
DeepLabV3 (Chen et al., 2017) was built to obtain multi-scale context. This
was done by using atrous convolutions with different rates. DeeplabV3Plus
(Chen et al., 2018) extends this by having low-level features transported from
the encoder to decoder.
2.4.4. Ensemble
Our ensemble comprised of 3 FCN models, each of the individual FCN model
was trained on one of the 3-fold cross-validation splits. During inference, the
predicted posterior probabilities of the segmentation maps were averaged to
generate the ensemble model prediction. The models were trained and inferred
on the image patch size of 256x256 at the highest resolution of WSI.
2.5. Loss function
Tumor regions were represented by a minuscule proportion of pixels in WSIs,
thereby leading to class imbalance. This issue was circumvented by training the
network to minimize a hybrid loss function. The hybrid cost function comprised
of cross-entropy loss and a loss function based on the Dice overlap coefficient.
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The dice coefficient is an overlap metric used for assessing the quality of seg-
mentation maps. The dice loss is an differentiable function that approximates
to dice-coefficient and is defined using the predicted posterior probability map
and ground truth binary image as defined in the Eq. 2. The cross-entropy loss
is defined in Eq. 3. In the equations, pi is the predicted posterior probability
map, and gi is the ground truth image.
DiceLoss = 1− 2
∑N
i pigi∑N
i p
2
i +
∑N
i g
2
i
(2)
CrossEntropyLoss =
N∑
i
(gilog(pi) + (1− gi)log(1− pi)) (3)
The total loss is defined as a linear combination of the two loss components
as defined in Eq. 4. The neural networks are trained by minimizing the total
loss. The α, β, γ are empirically assigned to the individual loss components. FG
and BG represent the foreground pixels that correspond to the tumor regions
and the background pixels that corresponded to non-tumor regions, respectively.
In this work we set α = 0.5, β = 0.25 and γ = 0.25.
TotalLoss = α∗CrossEntropyLoss+β ∗DiceLossBG+γ ∗DiceLossFG (4)
2.6. Uncertainty analysis
Uncertainty estimation is essential in assessing unclear diagnostic cases pre-
dicted by deep learning models. It helps pathologists/doctors to concentrate
more on the uncertain regions for their analysis. The need and challenges that
we might face in the context of uncertainty are discussed in (Begoli et al., 2019).
There exist two main sources of uncertainty, namely (1) Aleatoric uncertainty,
and (2) Epistemic uncertainty. Aleatoric uncertainty is uncertainty due to the
data generation process itself. In contrast, the uncertainty induced due to the
model parameters, which is the result of not estimating ideal model architec-
tures or weights to fit the given data, is known as epistemic uncertainty (Kendall
and Gal, 2017). Epistemic uncertainty can be approximated by using test time
18
Figure 6: Overview of training pipeline
Bayesian dropouts as discussed in (Leibig et al., 2017), which estimates uncer-
tainty by Montecarlo simulations with Bayesian dropout.
In the proposed pipeline, we estimate aleatoric uncertainty for each model
using test time augmentations, as introduced in (Gal and Ghahramani, 2016).
For epistemic uncertainty, we make use of the diversity of model architectures
and calculate uncertainty as described in equation 5.
varepistemic(x) ≈ Eφ∼{Φi}(φ(x|w)−E(φ∼{Φi}(φ(x|w)))2) (5a)
varaleatoric(x,Φi) ≈ Et∼TTA(Φi(x|w, t) (5b)
where Φi indicates trained model, where Φi ∈ {Φdensenet,Φinception,Φdeeplabv3}
and TTA denotes the set of possible test time data augmentations allowed. In
our case TTA ∈ {rotation, verticalflip, horizontalflip}.
2.7. Training pipeline
Figure 6 describes the training strategy utilized for training each of our
models. The batches for training were generated with an equal number of
tumor and non-tumor patches. This was done to prevent class imbalance or
19
Figure 7: Overview of Inference Pipeline
manifold shift issues and enforce proper training. All three models were trained
independently, with different folds of the data.
We made use of the transfer learning technique by using ImageNet(Deng
et al., 2009) pre-trained weights for encoders based on DenseNet and Inception-
ResNetV2. We made use of the models pre-trained on PascalVOC(Everingham
et al., 2010) in the case of DeeplabV3Plus. For the first two epochs, the encoder
section of the models were frozen, and only the decoder weights were made
trainable. For the remaining epochs, both the encoder and decoder parts were
trained, and the learning rate was reduced gradually. The learning rate was
decayed after every few epochs in a deterministic manner to allow for the model
to gradually converge.
2.8. Inference pipeline
Figure 7 provides an overview of the inference pipeline to generate tumor
probability maps and model uncertainty maps. In a typical WSI, the tissue
region occupies a smaller fraction when compared to the background glass slide,
hence for faster inference, the pre-processing step involved segmentation of tis-
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Figure 8: (Left to Right) A tissue mask overlayed on the WSI image at low resolution (level-4),
here the white region corresponds to the tissue mask; Uniform Patch Coordinate Sampling
Grid, here the points on the image act as centers from which high-resolution image patches
were extracted from the WSI.
sue region. This tissue segmentation mask was generated, as discussed in section
2.3.1. In order to facilitate extraction of patches from the WSI within the tissue
mask region a uniform patch-coordinate sampling grid was generated at lower
resolution as shown in Figure 8. Each point in the patch sampling grid was
rescaled by a factor to map to the coordinate space corresponding to WSI at its
highest resolution. From these scaled coordinate points as the center, fixed-size
high-resolution image patches were extracted from the WSI. We define sam-
pling stride as the spacing between consecutive points in the patch sampling
grid. The high-resolution patch size and the sampling stride controlled the over-
lap between consecutive extracted patches from the WSI. The main drawback
with patch-based segmentation of WSI was that the smaller patches could not
capture a wider context of the neighborhood. Moreover, stitching of the patch
segmentation introduced boundary artifacts (blockish appearance) in the tumor
probability heat-maps. We observed that the generated heat-maps were smooth
when the inference was done on overlapping patches with larger patch-size and
averaging the prediction probabilities at overlapping regions. Our experiments
suggested that 50% overlap between consecutive neighbouring patches was the
optimal choice as it ensured that a particular pixel in the WSI was seen at most
4-times during the heat-map generation. However, this approach increased the
21
Figure 9: Overview of pN-Staging pipeline
inference time by a factor of 4. We also observed that during inference increas-
ing the patch size by a factor of 4 when compared to the patch size used during
training (256x256) improved the quality of generated heat-maps. The gener-
ated heat maps obtained by single model with multiple input images varied
with different test time augmentations were used in the estimation of aleatoric
uncertainty map. Epistemic uncertainty map was estimated by using multiple
heat maps obtained from different models for a given input image.
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Table 4: Features extracted from the heatmap for predicting lymph node metastases type.
No. Feature description Threshold (p)
1 Largest tumor regions major axis length p=0.9 & p=0.5
2 Largest tumor region’s area p=0.5
3 Ratio of tumor region to tissue region p=0.9
4 Count of non-zero pixels p=0.9
5 Tumor regions area: maximum, mean, variance, skewness, and kurtosis p=0.9
6 Tumor regions perimeter: maximum, mean, variance, skewness, and kurtosis p=0.9
7 Tumor regions eccentricity: maximum, mean, variance, skewness, and kurtosis p=0.9
8 Tumor regions extent: maximum, mean, variance, skewness, and kurtosis p=0.9
9 Tumor regions solidity: maximum, mean, variance, skewness, and kurtosis p=0.9
10 Mean of all region’s mean confidence probability p=0.9
11 Number of connected regions p=0.9
2.9. pN-Staging Pipeline
The Figure 9 illustrates the overall pipeline for pN-Staging. The pipeline
comprises 4 blocks as described below:
• Pre-processing: The tissue regions in the WSIs were detected for patch
extraction.
• Heatmap generation: The extracted patches from the WSIs were passed
through the inference pipeline to generate the down-scaled version of the
tumor probability heatmaps.
• Feature extraction: The heatmaps were binarized by thresholding at 0.5
and 0.9 probabilities, and at each of these thresholds, the connected com-
ponents were extracted, and region properties were measured using scikit-
image(van der Walt et al., 2014) library. We computed 32 geometric and
morphological features of the probable metastases regions. Table 4 pro-
vides a description of all the features computed.
• Classification: The pN-stage was assigned to the patient based on all the
available lymph-node WSIs, taking into account their individual metas-
tases type (Table 1). We employed a simple count-based rule based on
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Figure 10: Overview of viable tumor burden pipeline
pN-staging as defined in Table 2. For predicting the metastases type, we
built an ensemble of Random Forest classifiers (Liaw et al., 2002) using
the extracted features.
2.10. Tumor burden estimation
We obtained the viable tumor region from the segmentation pipeline dis-
cussed. For the whole tumor region, initially, we attempted to use the same
segmentation pipeline and model it as a binary classification problem. However,
the model provided results that had an accuracy lesser than 10%. Therefore,
we adopted a heuristic method to calculate the tumor burden. First, the viable
tumor region was predicted. Morphological operations were applied to remove
some of the false positives and fill the holes. Next, the smallest convex hull
that contained the entire viable tumor region was calculated. Simultaneously,
a tissue mask was obtained using otsu thresholding. The convex hull was then
multiplied with the tissue mask to obtain the whole tumor segmentation. The
viable tumor burden was then calculated by taking the ratio of the area of the
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viable tumor and whole tumor. Figure 10 show an overview of the viable tumor
burden estimation. The results are shown in Figure 18.
3. Experimental analysis
In this section, we experimentally analyze the effectiveness of our proposed
methodologies for segmentation and classification models. We implemented our
neural networks using TensorFlow (Abadi et al. (2016)) software. We ran our
experiments on multiple desktop computers with NVIDIA Titan-V GPU with
12 GB RAM, Intel Core i7-4930K 12-core CPUs @ 3.40GHz, and 48GB RAM.
3.1. Lesion detection performance on CAMELYON
In this section, we detail some of the techniques specific to CAMELYON
dataset pre-processing and discuss the performance of various FCN architectures
and ensemble configurations for lesion detection on the CAMELYON16 test
dataset (n=139).
3.1.1. Tissue mask generation
In some of the CM17 cases, the Otsu’s thresholding failed because of the
black regions in WSI. Hence, prior to the application of image thresholding op-
eration, the pre-processing involved replacing black pixel regions in the WSI
back-ground with white pixels and median blurring with a kernel of size 7x7
on the entire image. Median blur aided in the smoothing of the tissue regions
and removal of noise at the tissue bordering the glass-slide region‘ while pre-
serving the edges of the tissue. Figure 11 illustrates the pipeline for tissue mask
generation with an example.
3.1.2. Dataset preparation
For training our model for lesion segmentation, we used training sets of both
CAMELYON16 and CAMELYON17 dataset, which had pixel-level annotations.
As noted by the challenge organizers, some of the WSIs were not exhaustively
annotated in the CAMELYON16 training set; we excluded them in our training
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Figure 11: An illustration of the intermediate results of tissue mask generation of WSI in
CM17 dataset.
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Table 5: The table gives the statistics of the tumor and non-tumor patches in each of the
cross-validation folds.
Patch label No. of patch coordinates
Fold-0 Fold-1 Fold-2
Training Non-Tumor 187034 196094 190424
Training Tumor 184467 194709 187440
Validation Non-Tumor 99742 90682 96352
Validation Tumor 99786 89544 96813
set preparation. So, in total, we had 628 WSIs for training (250 WSIs from
CAMELYON16 and 378 from CAMELYON17). We made a 3-fold stratified
cross-validation split of the training set to maximize the utilization of the lim-
ited number of WSIs. The stratification ensured that the ratio of negative to
metastases was maintained in all the three folds. From 628 WSIs, we randomly
sampled 571029 coordinates whose patches included regions from the tumor and
non-tumor tissue regions. A patch extracted from a WSI was labeled as a tu-
mor patch if it had non-zero pixels labeled as tumor pixels in the pathologists
manual annotation. Further, these extracted patch coordinates were split into
3-cross validation folds. Table 5 shows the distribution of the split in each of
the folds.
3.1.3. Training and inference configuration of ensemble FCN models
We experimented with following two types of Ensemble configuration:
• Ensemble-A: It comprised of the three different FCN architectures, as
described in section 2.7. The inference pipeline made use of patch size of
256 and extracted non-overlapping patches, as illustrated in Figure 9.
• Ensemble-B: It comprised of three replicated versions of a single FCN
architecture. The inference pipeline made use of a patch size of 1024 with
a 50% overlap between neighboring patches, as illustrated in Figure 12.
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Figure 12: The figure illustrates the overlap-stitch inference pipeline used in Ensemble-B
configuration.
In both the ensemble configurations, each model in the ensemble was trained
with one of the 3-fold cross-validation splits. All the models made use of pre-
trained weights with the fine-tuning procedure, as described in section 2.7. The
models were trained for ten epochs with a batch size of 32.
3.1.4. Lesion detection performance of Ensemble-A
Table 6 provides a summary of the Ensemble-A and its individual consti-
tuting FCN models. Our results showed that DenseNet-121 architecture had
higher sensitivity and reduced False positives when compared to other FCNs in
the ensemble configuration. It was also observed that Ensemble-A showed signif-
icant difference in FROC score (Appendix A.0.3) compared to its constituents.
The reason for this significant boost in the performance of Ensemble-A could
be attributed to the effect of averaging the heatmaps from multiple FCN mod-
els, thereby lowering the probabilities of uncertain or less confident regions and
hence eliminating the False Positives. Figure 13 illustrates the heatmaps gener-
ated by Ensemble-A and its constituent FCN models on a CAMELYON16 test
case.
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Figure 13: The figure shows the heat-maps overlayed on the WSI by FCN models in
Ensemble-A configuration. (Left to Right): DenseNet121 FCN, InceptionResNetV2 FCN,
DeepLabV3plus, Ensemble, (Patch Size: 256x256, Sampling Stride: 256 pixels).
Table 6: The table shows the FROC scores achieved on CAMELYON16 test set (n=139) by
FCN models in Ensemble-A configuration. Note the abbreviations: IRF - Inception-ResNetV2
FCN, DF- DenseNet-121 FCN, DL- DeepLabV3Plus, FP- False Positives
Average FPs /WSI Sensitivity
IRF (Fold-0) DF (Fold-1) DL (Fold-2) Ensemble-A
0.25 0.5 0.59 0.03 0.77
0.5 0.59 0.65 0.06 0.8
1 0.69 0.72 0.2 0.83
2 0.77 0.79 0.48 0.84
4 0.8 0.83 0.64 0.86
8 0.82 0.85 0.77 0.86
FROC Score 0.69 0.74 0.36 0.83
29
3.1.5. Lesion detection performance of Ensemble-B
From Table 6 it was evident that the performance of DenseNet-121 FCN per-
formed significantly better than the other two models in Ensemble-A. Hence,
we proposed to design an Ensemble-B comprising of three DenseNet-121 FCNs
as its constituents, each model was trained on one of the 3 cross-validation
folds. The results are summarized in Table 8. We observed an improvement in
FROC score for Ensemble-B (Appendix A.0.3) when compared to Ensemble-A.
We also observed that the performance of individual models in the ensemble
were similar (considering FROC score). However, this observation contrasted
with Ensemble-A, where the models showed significant difference in their FROC
scores. This also helped us to ascertain the fact that the performance differ-
ence in individual FCN models of Ensemble-A were not because of data vari-
ation seen between individual cross-validation folds. The Figure 14 illustrates
the heatmaps generated by Ensemble-B and its constituent FCN models on a
CAMELYON16 testcase. The Table 7 provides a summary of FROC scores
on CAMELYON16 testset (n=139) for various configurations of patch-size and
sampling stride. We observed that running inference on larger patch size en-
abled generation of smoother heatmaps and patch extraction with overlapping
stride gave better context at the patch borders thereby minimizing the block-
ish artifacts seen in the heatmaps. In the Figure 14 we observed that while
running inference on larger patch size, the model slightly struggled at tissue
borders which was evident from the confidence probability values. This was
primarily because we had trained the models on patch size of 256 and our train-
ing samples lacked regions from tissue border and glass-slide regions. Since,
there was a marginal difference in FROC scores between various ensemble con-
figurations (Table 7), in the interest of minimizing the computation time we
preferred to use Ensemble-A with patch-size and sampling stride set to 256
(non-overlapping patch acquisition) for running inference on CAMELYON17
testing dataset (n=500).
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Table 7: The table shows the FROC scores on CAMELYON16 test set (n=139) for various
configurations of model, patch-size, and sampling-stride.
Model Patch size Sampling stride FROC score
Ensemble-A 256 256 0.83
Ensemble-B 256 256 0.84
Ensemble-B 1024 1024 0.86
Ensemble-B 1024 512 0.85
Figure 14: The figure shows the heat-map overlayed on the WSI by FCN models in Ensemble-
B configuration. (Left to Right): 3 DenseNet121 FCN models trained on cross-validation
folds: 1, 0 and 2 respectively and Ensemble-B, (Patch Size: 1024x1024, Sampling Stride: 512
pixels).
Table 8: The table shows the FROC scores achieved on CAMELYON16 test set (n=139) by
FCN models in Ensemble-B configuration. Note the abbreviations: DF- DenseNet-121 FCN,
FP- False Positives.
Average FPs /WSI Sensitivity
DF (Fold-0) DF (Fold-1) DF (Fold-2) Ensemble-B
0.25 0.56 0.56 0.61 0.77
0.5 0.65 0.63 0.69 0.84
1 0.71 0.70 0.76 0.85
2 0.77 0.75 0.81 0.88
4 0.82 0.80 0.84 0.88
8 0.86 0.86 0.88 0.89
FROC Score 0.73 0.72 0.77 0.85
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Table 9: Details of our CM17 train and validation set split
Dataset No. of WSIs per each metastasis type
Negative ITC Micro Macro Total
Train set 100 26 35 44 215
Validation set 318 35 64 88 285
3.2. Lymph-node metastases type classification
In this section we detail and discuss the dataset preparation and training
methodology of Random Forest classifiers for metastases type classification.
3.2.1. Dataset preparation
The CM17 training dataset (Table 3) had 100 patients and each patient had
5 WSIs with their corresponding metastases labels (total 500 WSIs). We split
100 training patients into 43 patients as train set and the remaining 57 patients
as validation set. The train set comprised of patients which had atleast one of
their WSIs with pixel level annotation. The Table 9 shows the distribution of
WSIs in terms of metastases type between train and validation sets, our split
strategy ensured that the distribution of metastases type between the two splits
were similar.
3.2.2. Training methodology
We generated tumor probability heatmaps for all the 500 WSIs using Ensemble-
A configuration (section 3.1.3) and extracted all the features listed in Table 4.
Post generation of features, we cleaned the training set by removing some of the
outlier points. The outliers were detected based on threshold-based heuristics
like the presence of significantly large tumor false-positive regions in negative
cases, etc. For the purpose of classifier selection, feature elimination and hyper-
parameter tuning we initially trained our classifiers on the train set (n=215)
and validated on the held-out validation set (n=285). Our experimentation on
various classifiers showed that the optimal performance in-terms of classification
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accuracy (90.18%) and Cohen’s kappa score (0.9164) on held-out validation set
was achieved with Random Forest classifier with 100 trees. Figure 15 shows
the confusion matrix and the feature importance ranking by the Random For-
est classifier. From Table 9, we observed that the data distribution was highly
class imbalanced, with negative cases being majority class and ITC cases being
minority class. This lead to mis-classifications between ITC and negative cases,
as evident in the confusion matrix.
We further experimented by training another Random Forest classifier on the
complete training set (n=500) in order to maximize the utilization of training
points. The 5-fold cross-validation showed an average accuracy score of 90%,
and its performance was similar to the model trained on train set (n=215).
We refer to the above two trained models as RF-PI and RF-CI (Random Forest
classifiers trained on the partial and complete training set with imbalanced class
data, respectively).
3.2.3. Data balancing
In order to handle the class imbalance problem, one of the techniques pro-
posed in the literature is oversampling by synthetically generating minority class
samples using SMOTE algorithm. (Chawla et al., 2002). However, this method
can introduce noisy samples when the interpolated new samples lie between
marginal outliers and inliers. This problem is usually addressed by removing
noisy samples by using under-sampling techniques like Tomek’s link (Tomek,
1976) or nearest-neighbors. We proposed to balance our training data using
a SMOTETomek (Batista et al., 2004) algorithm, a combination of SMOTE
and Tomek’s link performed consecutively. We separately balanced our train
set (n=215) split and the complete training set (n=500). We independently
trained two Random Forest classifiers using these two balanced datasets. We
refer to these two trained models as RF-PB and RF-CB (Random Forest classi-
fiers trained on Partial and Complete training set, which are class Balanced data
respectively). Table 10 provides the results of the validation study performed on
all four models. We observed that post-class balancing of the training dataset,
33
Confusion Matrix of RF-PI Feature Importance
Figure 15: (a) Confusion Matrix of Random Forest classifier trained on imbalanced train
set predicted on held-out validation set, (b) Feature importance ranking by Random Forest
classifier for metastases classification. The green bars are the feature importance of the forest,
along with their inter-trees variability (standard deviation). The feature importance shows
that the most important feature for metastases classification is largest tumor region’s long
axis/diameter, which corroborates to pathologist way of determining the metastases type
from the WSI. Note: t90 and t50 indicate heatmaps thresholded at 0.9 and 0.5 probability
values, pixels gt 90 indicate number of non-zero pixels in the binary image after thresholding
the heatmap 0.9 probability.
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Table 10: The table provides the validation results of the four Random Forest classifiers, each
trained on different subsets of the training data. Note: For the models RF-PI and RF-PB,
held-out validation existed, whereas, for the other two models, it was not available as it was
trained on the entire training set, and hence N.A (not applicable) is mentioned in the table.
For all the models, 5-fold cross-validation accuracy was estimated on their respective training
sets. These values are provided as mean (standard deviation).
Accuracy (%)
Classifier 5-fold CV Validation set
RF-PI 87 (0.06) 90.18
RF-PB 92 (0.03) 87.02
RF-CI 89.89 (0.03) N.A
RF-CB 94.83 (0.02) N.A
Table 11: Segmentation results on held-out test set of DigestPath
Models Dice
DeepLabV3Plus 0.81
DenseNet-121 FCN 0.84
Inception-ResNetV2 FCN 0.84
Ensemble 0.86
the 5-fold cross-validation accuracy scores improved by a margin of 5%.
3.2.4. Ensembling classifiers
We proposed an ensemble strategy for combining the predictions of all the
four trained Random Forest classifiers. The ensembling was based on the ma-
jority voting principle, and in case of a tie, the higher metastases category was
selected. We refer to this model as RF-Ensemble.
3.3. Segmentation performance on DigestPath
In this section we discuss specific details on the training and inference strate-
gies on DigestPath dataset. We split the training data (n=725) into 3-fold cross-
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Figure 16: (Clockwise from top left) WSI Image; Ground truth of the tumor; Prediction
probability of the ensemble pipeline; Prediction with threshold of 0.5
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validation sets, each set of data was used to train the individual models in the
ensemble. We extracted a total of 80,000 patches from the entire training data.
We trained each model with a patch size of 256 and a batch size of 32, with
Adam optimizer.
In the case of inference, we made use of patches with dimension 256 x 256,
with 50% of overlap and a batch size of 32. We considered 0.5 as a threshold
value to generate a segmentation binary mask on a predicted probability map.
Figure 16 illustrates an example of the segmentation map generated by our
ensemble model. We tested our trained models on a subset of the training set
(n=25) reserved for our internal testing set, and their corresponding results are
tabulated in Table 11.
3.4. Segmentation performance on PAIP
In this section we elaborate on the training and inference details for seg-
mentation on the PAIP dataset. For the tissue mask, we first performed Otsu
thresholding on the HSV version of the slide image. We then performed the
closing morphological operation with a kernel size of 20, followed by an opening
operation with a kernel size of 5 and finally a dilation operation with a kernel
size of 20.
We split the training data (n=50) into five cross-validation folds and used
three of those folds for training the models of the ensemble. The data was split
into five folds as opposed to three folds to ensure that each training set had
at least 40 samples. We extracted a total of 200,000 patches from the entire
training data with equal contributions from each training sample. We trained
with a patch size of 256 and a batch size of 32.
For the inference, we used patches of 1024 and a batch size of 16. For the
threshold, we experimented with a range of values and chose 0.5 as it gave opti-
mal segmentation performance on the validation set(n=10). We observed that
setting lower threshold(0.5) resulted in false positives and higher threshold(0.9)
led to under-segmentation.
Figure 17 illustrates an example of the segmentation map generated by our
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Figure 17: (Clockwise from top left) WSI Image; Ground truth of the tumor; Prediction
probability of the ensemble pipeline; Prediction with threshold of 0.5
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Table 12: Segmentation results on validation set of PAIP
Model Jaccard Score
DeepLabV3Plus 0.681786
Inception-ResnetV2 0.685771
Densenet 0.679107
Ensemble 0.701621
ensemble model. We tested our trained models on the validation set (n=10),
and their corresponding results are tabulated in Table 12.
3.5. Viable Tumor Burden
Figure 18 shows the whole tumor region predictions obtained by the method-
ology described 2.10. The first image shows that this pipeline gives a good
approximation to the whole tumor region. Most of the samples fit into this
category. Our pipeline failed in two scenarios. One is when the segmentation
pipeline predicted viable tumors in discrete dispersed regions. This is illustrated
in the second example in Figure 18 where there is a spurious prediction apart
from the main tumor prediction. The other failure case is when the actual whole
tumor region is larger than the convex hull boundary of the actual viable tumor
region. The third sample in figure 18 demonstrates this failure.
3.6. Uncertainty analysis
In this section, we demonstrate and interpret the results of our uncertainty
analysis on all three digital pathology datasets.
3.6.1. DigestPath uncertainty maps
Figure 19 provides an illustration of tumor probability and uncertainty maps
for a held-out test case from the DigestPath dataset. Figure 19(1,2,3,4,5)(b)
corresponds to ground truth image overlayed on the tissue image, while Figure
19(1,2,3,4,5)(c) corresponds to tumor probability heatmap overlayed on tissue
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Figure 18: (Left to Right) Viable tumor prediction; Whole tumor prediction; Whole tumor
Ground Truth
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region. Figures 19(1, 2, 3)(d) describes aleatoric uncertainty with DenseNet,
InceptionNet, and DeeplabV3Plus respectively. Since the patches considered
for inference in the case of DigestPath were of 256 × 256, aleatoric uncertainty
can be observed in various tumors region. Figure 19(4)(d) describes epistemic
uncertainty, where the uncertain region clearly corresponds to the boundary of
the tumor tissue region, while Figure 19(5)(d) describes combined uncertainties
(average of aleatoric uncertainties for all models along with epistemic uncer-
tainty across the models), which points out various tumorous and boundary
regions. In Figure 19(4, 5)(c), we observed ensemble prediction reduced the
number of false positives, their by increasing overall dice score to 0.86, which is
about 0.04-0.06 of dice score improvement when compared to individual model.
3.6.2. PAIP uncertainty maps
In the Figure 20 provides an illustration of tumor probability and uncertainty
maps for a held-out test case from PAIP dataset. Our observations were similar
to as discussed in section 3.6.1.
3.6.3. CAMELYON uncertainty maps
In Figure 21 provides an illustration of tumor probability and uncertainty
maps for a held-out test case from CAMELYON dataset. Our observations were
similar to as discussed in section 3.6.1.
3.7. Transfer learning between cancer sites
To test transfer learning between cancer sites, we first tried inferencing on
the DigestPath dataset with a model trained on the CAMELYON dataset. As
it can be observed from Figure 22, the model learned inherent tissue concepts
that were common between both sites. The similar staining pattern and nuclei
similarity could have contributed to this observation.
Subsequently, we conducted a comparative analysis on the model weight
initialisation. We trained two models on the PAIP dataset; One pre-trained on
the CAMELYON dataset and one pre-trained on the Imagenet dataset (Deng
et al., 2009). We observed that the former model converged at a faster rate.
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(1) DenseNet model predictions with aleatoric uncertainty (dice = 0.82)
(2) InceptionNet model predictions with aleatoric uncertainty (dice = 0.78)
(3) DeepLabv3Plus model predictions with aleatoric uncertainty (dice = 0.80)
(4) Ensemble Predictions with epistemic uncertainty (dice = 0.86)
(5) Ensemble predictions with combined uncertainty (dice = 0.86)
Figure 19: In the figure (a) WSI, (b) Ground truth image overlayed on the tissue region,
(c) Tumor probability heatmap overlayed on the tissue region, (d) Corresponding uncertainty
map.
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(1) DenseNet model predictions with aleatoric uncertainty (dice = 0.88)
(2) InceptionNet model predictions with aleatoric uncertainty (dice = 0.88)
(3) DeepLabv3Plus model predictions with aleatoric uncertainty (dice = 0.88)
(4) Ensemble Predictions with epistemic uncertainty (dice = 0.91)
(5) Ensemble predictions with combined uncertainty (dice = 0.91)
Figure 20: In the figure (a) WSI, (b) Ground truth image overlayed on the tissue region,
(c) Tumor probability heatmap overlayed on the tissue region, (d) Corresponding uncertainty
map.
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(1) DenseNet model predictions with aleatoric uncertainty (dice = 0.91)
(2) InceptionNet model predictions with aleatoric uncertainty (dice = 0.89)
(3) DeepLabv3Plus model predictions with aleatoric uncertainty (dice = 0.88)
(4) Ensemble Predictions with epistemic uncertainty (dice = 0.94)
(5) Ensemble predictions with combined uncertainty (dice = 0.94)
Figure 21: In the figure (a) WSI, (b) Ground truth image overlayed on the tissue region,
(c) Tumor probability heatmap overlayed on the tissue region, (d) Corresponding uncertainty
map.
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Figure 22: (Left to Right) DigestPath Slide; Ground truth; Tumor prediction with Camelyon
model; Aleatoric uncertainty
Figure 23: Training loss with Camelyon pre-trained weights and ImageNet pre-trained weights
for the PAIP dataset
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Figure 23 illustrates this comparison. This observation indicates that models
trained on pathology datasets could serve as a better starting point compared
to natural image datasets.
3.8. Model generalizability
To test the generalizability of the model we conducted the model inferences
on TCGA colon dataset (gdc), the model was able to accurately classify between
tumorous and normal cells as seen in the Figure 24. Even though the model
was trained on DigestPath data, our model could generalize well on datasets
coming from other sources, Figures 24(1, 2, 3, 4, 5)(b) describes the predicted
high probable tumor regions, while in the Figure 24(1, 2, 3, 4, 5)(c) describes
corresponding aleatoric and epistemic uncertainties in the prediction. In future,
we plan to extend this generalizability study by getting pathologists annotations
done and precisely assessing the seg mentation performance.
3.9. Hardmining
Our patch extraction scheme from the whole-slide images were based on ran-
dom uniform sampling. However, this led to some hard examples being excluded
from the training set which resulted in the model’s poor performance on such
regions of WSI. Therefore, we attempted to solve this issue by hardmining the
poorly performing regions in WSI and fine-tuning the trained model with this
hardmined set.
For the experimental analysis with the PAIP dataset, we first extracted
80,000 random patches as the initial training set and trained a model on it. We
empirically defined patches that scored less than 0.4 on the Jaccard index as
regions were the model performed poorly. We than inferred on the entire dataset
and extracted all patches that meet this criterion. In this manner, we obtained
a total of 70,000 patches as the hardmined set. We then continued training the
model after substituting the training set with the hardmined set. However, at
every epoch, we observed the model’s accuracy on validation set reduced. We
theorized that by training only on the failure cases, the model forgets the initial
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(1) DenseNet model predictions with aleatoric uncertainty
(2) InceptionNet model predictions with aleatoric uncertainty
(3) DeepLabv3Plus model predictions with aleatoric uncertainty
(4) Ensemble Predictions with epistemic uncertainty
(5) Ensemble predictions with combined uncertainty
Figure 24: In the figure (a) WSI, (b) Tumor probability heatmap overlayed on the tissue
region, (c) Corresponding uncertainty map.
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Table 13: Comparisons with different approaches to automated pN-Staging in CAMELYON17
challenge. Our score reported in the table is from open public leader board. Our best perform-
ing method stood rank-3 on the leader-board (Accessed on: 31-Dec-2019). The table shows
the performance of individual Random Forest classifiers in the ensemble and RF-Ensemble
classifier.
Method Cohen Kappa Score Rank
Lee et al. (2019) 0.9570 1
Pinchaud (2019) 0.9386 2
Ours (RF-Ensemble) 0.9090 3
Ours (RF-PI) 0.8971 12
Ours (RF-PB) 0.9027 9
Ours (RF-CI) 0.8889 18
Ours (RF-CB) 0.9057 6
training set. So, we tried an alternative where we concatenated the patches of
both the initial training set and the hard-mined set and trained the model with
this combined set. The model’s accuracy reduced with this method as well,
albeit at a slower rate.
To investigate this occurrence, we examined the patches obtained from hard-
mining and analysed them. We found groups of patches that were highly similar
to each other. This was because the regions where the model failed were larger in
size compared to the dimensions with which the patches were extracted. There-
fore, the hardmining algorithm extracts several patches from the same region.
As a result, this set was less representative of the data compared to the first
set of randomly extracted patches. We observed a similar pattern in the other
datasets as well.
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Teams Dice
kuanguang 0.807
zju realdoctor 0.792
TIA Lab 0.787
Ours 0.782
Table 14: The table shows the top segmentation scores on DigestPath testset
4. Challenge Results
4.1. Performance on CAMELYON17 Challenge
Table 13 compares the results between our proposed approach and other
published results on CAMELYON17 testing dataset (n=500). Our best per-
forming model was RF-Ensemble, which gave a Cohen’s kappa score of 0.9090,
placing 3rd in Open Leaderboard (out of 120 valid submission entries).
4.2. Performance on DigestPath Challenge
In the case of the DigestPath challenge, we submitted our ensemble model
and obtained a Dice score of 0.78 on test set. The scores of all the top-performing
teams are tabulated in the Table. 14.
4.3. Performance on PAIP 2019 Challenge
The Table 15 summarises the scores for the top entries. Task 1 is evaluated
with the Jaccard metric. For Task 2, first, the absolute accuracy is calculated,
and then this score is weighted with the Task 1 score of the corresponding
case. For Task 1, all the participants utilized deep learning methods, albeit
with different architectures. For Task 2, all the participants used deep learning
methods. However, our heuristic based algorithm performed better than most
deep learning methods.
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Table 15: The table shows the top 5 entries of PAIP 2019. Task 1 corresponds to Viable tumor
segmentation and Task 2 corresponds to Viable tumor burden estimation. Note: FNLCR:
Frederick National Laboratory for Cancer Research
Team Task 1 Task 2
FNLCR 0.789 0.752
Sichuan University 0.777 NA
Ours 0.750 0.6337
Alibaba 0.672 0.6199
Sejong University 0.665 0.6330
Figure 25: User Interface of the software
50
5. Open Source Contribution
We developed an open-source application (Haran Rajkumar, 2019) on top of
our segmentation pipeline. The application 25 can load WSI images, perform
segmentation, and calculate the uncertainties. It features an API with which
researchers can utilize the segmentation pipeline within their applications. Con-
versely, the application’s modular structure allows for researchers to test their
segmentation pipeline with the application’s GUI as well. The slide viewer was
built using OpenSlide (Goode et al., 2013) and OpenSeadragon (Antoine Van-
decreme).
6. Discussion and Conclusion
We developed an automated end-to-end framework for tumor tissue segmen-
tation and whole slide image analysis that showed state-of-the-art results on
three publicly available histopathology challenges. We approached the problem
of segmentation of gigapixel WSI images using the divide and conquer strategy
by dividing the large image into computationally feasible patch sizes and running
segmentation algorithms on patches and stitching segmented patches to gener-
ate the segmentation of the entire WSI. We approached the problem of patch
image segmentation using fully convolutional neural networks (FCN). FCNs are
encoder-decoder based architectures employed for generating dense pixel-level
classification. We used some of the state-of-the-art CNNs on natural image tasks
as encoders for our FCNs, and the decoder was basically a learnable upsampling
module to generate dense predictions. Our segmentation framework is an en-
semble comprising of multiple FCN architectures, each independently trained on
different subsets of the training data. The ensemble generated the tumor prob-
ability map by averaging the posterior probability maps of all the FCNs. The
ensemble approach showed superior segmentation performance when compared
to its individual constituting FCNs. The patch-based segmentation methods for
large-sized images suffer from loss of neighboring context information at patch
borders. We attempted to address this issue during inference by using a larger
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patch size and averaging overlapping patch regions posterior probability maps
while stitching tumor probability maps for WSI. Depending upon tissue area
covered on glass-slide, our inference pipeline takes about approximately 30-75
minutes for generating the entire tumor probability map. In addition to the gen-
eration of tumor heat-map, we also incorporated a methodology for generating
uncertainty maps based on model and data variability. These uncertainty maps
would assist in better interpretation by pathologists and fine-tuning the model
with uncertain regions. Our proposed hard-mining approach showed decreased
segmentation performance because of the adopted fine-tuning procedure on the
trained model. Hence, one of the directions of our future work would involve
developing effective methodologies for the online extraction of good representa-
tive patches from WSI during the training phase rather than the extraction of
a fixed set of random patches(Lee et al., 2019; Pinchaud, 2019). Other areas
to explore would be in the design of efficient and multi-resolution FCN archi-
tectures for capturing multi-resolution information from WSI images (Graham
et al., 2019). Our experimental results on transfer learning showed that pre-
training models with different histopathology datasets could act as good starting
points for training models were pathology datasets are limited. Post-processing
techniques could be one of the directions to improve generated WSI segmen-
tation, techniques such as patch-based conditional random fields (Kra¨henbu¨hl
and Koltun, 2011; Li and Ping, 2018) could be employed to refine the generated
segmentation masks rather than employing hardcoded threshold values. The
segmentation of WSIs is usually the primary step for many analysis tasks such
as metastases classification and estimation of tumor burden. In this regard, we
developed an automated pipeline for lymph node metastases classification and
pN-staging. We proposed an ensemble of multiple Random Forest classifiers,
each trained on different subsets of the training data. The training data was
prepared by extracting meaningful features from a pathologist’s viewpoint from
the tumor probability maps. We also demonstrated the efficacy of our synthetic
samples in addressing class imbalance datasets for such classification tasks.
Our method for tumor burden estimation used an empirical method for
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estimating the whole tumor region. However, it still performed on par with
other deep learning approaches that modeled it as a segmentation problem. This
shows that the convex hull is a good approximation and also computationally
inexpensive. This method could be developed further by incorporating learning-
based methods. For example, the convex hull output could be used as an initial
point for active contours-based models (Kass et al., 1988).
7. Author Contributions
MK, HR and AK developed the generalised pipeline together. MK, HR and
AK experimented on CAMELYON, PAIP and DigestPath respectively. MK su-
pervised HR and AK on the experimentation. HR and AK developed the open-
source software together. MK, HR and AK wrote and revised the manuscript.
GK and BS edited the manuscript, supervised and funded the study.
53
Appendix A. Evaluation metrics
Appendix A.0.1. Dice Coefficient
The Dice is a metric used to measure the overlap between two given sets.
In the case of segmentation, dice coefficient measures the overlap between the
proposed model prediction(P ) and the expert pathologists’ ground truth (GT ).
This was the evaluation metric used in the DigestPath19 challenge. Mathemat-
ically, dice coefficient can be expressed as equation A.1.
Dice(P,GT ) =
2 ∗ |P ∩GT |
|P ∪GT | (A.1)
Appendix A.0.2. Jaccard Coefficient
The Jaccard metric, similar to the Dice coefficient, measures the intersec-
tion over union between two given sets. For the task of segmentation, Jaccard
coefficient measures overlap between prediction (P ) and expert pathologists’
ground truth (GT ). This was the evaluation metric used in the PAIP 2019
(PAIP, 2019) challenge. Mathematically, Jaccard coefficient can be expressed
as equation A.2.
Jaccard(P,GT ) =
|P ∩GT |
|P ∪GT | (A.2)
Appendix A.0.3. FROC
One of the metrics used in CM16 challenge for lesion-based evaluation was
free-response receiver operating characteristic (FROC) curve. The FROC curve
was defined as the plot of sensitivity versus the average number of false-positives
per image. We used CM16 challenge testing dataset for evaluating the perfor-
mance of our algorithms for lesion detection/localization. The detection/localization
performance was summarized using Free Response Operating Characteristic
(FROC) curves. This was similar to ROC analysis, except that the false positive
rate on the x-axis is replaced by the average number of false positives per WSI.
In the CM16 challenge, a true positive was considered, if the location of the
detected region was within the annotated ground truth lesion.
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• If there were multiple findings for a single ground truth region, they were
counted as a single true positive finding and none of them were counted
as a false positive.
• All detections that were not within a specific distance from the ground
truth annotations were counted as false positives.
The final FROC score was defined as the average sensitivity at 6 predefined
false positive rates: 1/4, 1/2, 1, 2, 4, and 8 FPs per whole slide image.
Appendix A.0.4. Cohen’s kappa score
Cohen’s kappa (Fleiss and Cohen, 1973) is a statistic that measures the inter-
rater reliability for categorical variables. In CM17 challenge for evaluating pN-
staging of the patients the metric used was Cohen’s kappa with five classes and
quadratic weights. The kappa metric ranges from -1 to +1, where 1 represented
perfect agreement with the raters, and 0 represented the amount of agreement
that can be expected by random chance and, a negative value represented lower
than chance agreement.
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